SMTL ID : 9esc.1

Holo IDO with a bound inhibitor

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 1.95 Å

Oligo State

homo-dimer

Ligands

2 x HEM: PROTOPORPHYRIN IX CONTAINING FE(Non-covalent)

HEM.1: 23 residues within 4Å: Chain A: Y.141, F.178, V.181, S.182, V.185, F.229, I.232, F.241, S.278, A.279, G.280, F.285, R.358, H.361, I.364, V.365, Y.368, I.369, L.399, F.402, L.403, V.406 Ligands: 01.2 23 PLIP interactions: 23 interactions with chain A, Hydrophobic interactions: A:F.178, A:F.178, A:V.181, A:V.185, A:F.229, A:F.229, A:I.232, A:F.241, A:A.279, A:F.285, A:I.364, A:V.365, A:Y.368, A:Y.368, A:I.369, A:L.399, A:F.402, A:F.402, A:L.403 Salt bridges: A:R.358 pi-Stacking: A:F.178, A:F.229 Metal complexes: A:H.361 HEM.3: 23 residues within 4Å: Chain B: Y.141, F.178, V.181, S.182, V.185, F.229, I.232, F.241, S.278, A.279, G.280, F.285, R.358, H.361, I.364, V.365, Y.368, I.369, L.399, F.402, L.403, V.406 Ligands: 01.4 24 PLIP interactions: 24 interactions with chain B, Hydrophobic interactions: B:F.178, B:F.178, B:V.181, B:V.185, B:F.229, B:F.229, B:F.229, B:I.232, B:F.241, B:A.279, B:F.285, B:I.364, B:V.365, B:Y.368, B:Y.368, B:I.369, B:L.399, B:F.402, B:F.402, B:L.403 Hydrogen bonds: B:S.278 Salt bridges: B:R.358 pi-Stacking: B:F.178 Metal complexes: B:H.361

2 x 01: (~{S})-[(7~{a}~{R})-2-cyclopentyl-5,6,7,7~{a}-tetrahydroimidazo[5,1-b][1,3]thiazol-3-yl]-cyclohexyl-methanol

01.2: 11 residues within 4Å: Chain A: Y.141, C.144, F.178, F.179, S.182, F.241, L.249, G.277, S.278, A.279 Ligands: HEM.1 9 PLIP interactions: 9 interactions with chain A Hydrophobic interactions: A:Y.141, A:F.178, A:F.178, A:F.179, A:F.241, A:L.249, A:L.249 Hydrogen bonds: A:S.278, A:A.279 01.4: 12 residues within 4Å: Chain B: Y.141, C.144, V.145, F.178, F.179, S.182, F.241, L.249, G.277, S.278, A.279 Ligands: HEM.3 7 PLIP interactions: 7 interactions with chain B Hydrophobic interactions: B:Y.141, B:F.179, B:F.241, B:L.249, B:L.249 Hydrogen bonds: B:S.278, B:A.279

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Cren, S. et al., SAR and cellular potency optimization of novel heme-binding IDO1 inhibitors. To Be Published

Release Date

2025-03-05

Peptides

Indoleamine 2,3-dioxygenase 1: AB

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

B
B

Indoleamine 2,3-dioxygenase 1

Related Entries With Identical Sequence